- Home
- FLUX vs COEP Comparison
FLUX vs COEP Comparison
Compare FLUX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- COEP
- Stock Information
- Founded
- FLUX N/A
- COEP 2017
- Country
- FLUX United States
- COEP United States
- Employees
- FLUX N/A
- COEP N/A
- Industry
- FLUX Industrial Machinery/Components
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLUX Miscellaneous
- COEP Health Care
- Exchange
- FLUX Nasdaq
- COEP Nasdaq
- Market Cap
- FLUX 25.4M
- COEP 27.4M
- IPO Year
- FLUX N/A
- COEP N/A
- Fundamental
- Price
- FLUX $1.83
- COEP $11.63
- Analyst Decision
- FLUX Strong Buy
- COEP
- Analyst Count
- FLUX 2
- COEP 0
- Target Price
- FLUX $6.00
- COEP N/A
- AVG Volume (30 Days)
- FLUX 154.8K
- COEP 54.9K
- Earning Date
- FLUX 08-15-2025
- COEP 08-15-2025
- Dividend Yield
- FLUX N/A
- COEP N/A
- EPS Growth
- FLUX N/A
- COEP N/A
- EPS
- FLUX N/A
- COEP N/A
- Revenue
- FLUX $63,074,000.00
- COEP $62,874.00
- Revenue This Year
- FLUX $11.10
- COEP N/A
- Revenue Next Year
- FLUX $12.66
- COEP N/A
- P/E Ratio
- FLUX N/A
- COEP N/A
- Revenue Growth
- FLUX N/A
- COEP N/A
- 52 Week Low
- FLUX $1.15
- COEP $2.31
- 52 Week High
- FLUX $3.99
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- FLUX 48.43
- COEP 66.85
- Support Level
- FLUX $1.88
- COEP $10.00
- Resistance Level
- FLUX $2.15
- COEP $11.70
- Average True Range (ATR)
- FLUX 0.22
- COEP 0.89
- MACD
- FLUX -0.02
- COEP 0.30
- Stochastic Oscillator
- FLUX 16.25
- COEP 76.97
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.